These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38061922)

  • 1. Association between remnant cholesterol and incident atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation.
    Tada H; Kaneko H; Suzuki Y; Okada A; Takeda N; Fujiu K; Morita H; Ako J; Node K; Takeji Y; Takamura M; Yasunaga H; Komuro I
    J Clin Lipidol; 2024; 18(1):3-10. PubMed ID: 38061922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population-based study.
    Tada H; Kaneko H; Suzuki Y; Okada A; Takeda N; Fujiu K; Morita H; Ako J; Node K; Takeji Y; Takamura M; Yasunaga H; Komuro I
    Eur J Clin Invest; 2024 Feb; 54(2):e14119. PubMed ID: 37916502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years.
    Seki H; Kaneko H; Morita H; Itoh H; Morita K; Matsuoka S; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Yano Y; Nakamura S; Node K; Yasunaga H; Komuro I
    Am J Cardiol; 2021 Aug; 152():150-157. PubMed ID: 34140140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of retinal atherosclerosis assessed using Keith-Wagener-Barker system with incident heart failure and other atherosclerotic cardiovascular disease: Analysis of 319,501 individuals from the general population.
    Matsuoka S; Kaneko H; Okada A; Itoh H; Suzuki Y; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Nakamura S; Node K; Yasunaga H; Komuro I
    Atherosclerosis; 2022 May; 348():68-74. PubMed ID: 35292151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign Prostatic Hyperplasia and Incident Cardiovascular Disease.
    Suzuki Y; Kaneko H; Okada A; Fujiu K; Jo T; Takeda N; Tanaka A; Node K; Morita H; Yasunaga H; Komuro I
    Circ J; 2024 Feb; 88(3):408-416. PubMed ID: 38246651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
    J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease.
    Xiao Z; Lin Z; Xu L; Xu W; Huang H; Wang Y; Cao S; Xie Z; Liao W; Liao Y; Bin J; Feng W; Chen Y
    Eur J Prev Cardiol; 2023 Nov; 30(17):1924-1934. PubMed ID: 37708385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.
    Kaneko H; Yano Y; Itoh H; Morita K; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Node K; Carey RM; Lima JAC; Oparil S; Yasunaga H; Komuro I
    Circulation; 2021 Jun; 143(23):2244-2253. PubMed ID: 33886370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantitative assessed proteinuria and risk of heart failure: analysis of a nationwide epidemiological database.
    Fukui A; Kaneko H; Okada A; Yano Y; Itoh H; Matsuoka S; Morita K; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Nakamura S; Nishiyama A; Node K; Yokoo T; Nangaku M; Yasunaga H; Komuro I
    Nephrol Dial Transplant; 2022 Aug; 37(9):1691-1699. PubMed ID: 34491362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Dependent Association Between Modifiable Risk Factors and Incident Cardiovascular Disease.
    Kaneko H; Yano Y; Okada A; Itoh H; Suzuki Y; Yokota I; Morita K; Fujiu K; Michihata N; Jo T; Yamaguchi S; Takeda N; Morita H; Node K; Yamauchi T; Nangaku M; Kadowaki T; McEvoy JW; Lam CSP; Yasunaga H; Komuro I
    J Am Heart Assoc; 2023 Jan; 12(2):e027684. PubMed ID: 36628975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
    Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
    Diabetologia; 2023 Dec; 66(12):2238-2249. PubMed ID: 37776347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor.
    Hu WS; Lin CL
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1977-1986. PubMed ID: 36881169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of dementia differs across cardiovascular diseases and types of dementia - Data from a nationwide study.
    Kauko A; Engler D; Niiranen T; Ortega-Alonso A; Schnabel RB
    J Intern Med; 2024 Feb; 295(2):196-205. PubMed ID: 37899293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.
    Quispe R; Martin SS; Michos ED; Lamba I; Blumenthal RS; Saeed A; Lima J; Puri R; Nomura S; Tsai M; Wilkins J; Ballantyne CM; Nicholls S; Jones SR; Elshazly MB
    Eur Heart J; 2021 Nov; 42(42):4324-4332. PubMed ID: 34293083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of Menstrual Cycle Regularity and Length With Cardiovascular Diseases: A Prospective Study From UK Biobank.
    Huang C; Lin B; Yuan Y; Li K; Xu B; Zhang P; Wei X; Wang W; Liu W; Deng Y; Liu D; Lin J; Huang Y; Zhang H
    J Am Heart Assoc; 2023 Jun; 12(11):e029020. PubMed ID: 37222132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Profile and Subsequent Cardiovascular Disease among Young Adults Aged < 50 Years.
    Kaneko H; Itoh H; Kiriyama H; Kamon T; Fujiu K; Morita K; Michihata N; Jo T; Takeda N; Morita H; Yasunaga H; Komuro I
    Am J Cardiol; 2021 Mar; 142():59-65. PubMed ID: 33301771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
    Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
    Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease.
    Shavadia JS; Zheng Y; Green JB; Armstrong PW; Westerhout CM; McGuire DK; Cornel JH; Holman RR; Peterson ED
    Am Heart J; 2019 Dec; 218():92-99. PubMed ID: 31715435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD-AF.
    Ambrosio G; Camm AJ; Bassand JP; Corbalan R; Kayani G; Carluccio E; Mantovani LG; Virdone S; Kakkar AK;
    ESC Heart Fail; 2021 Apr; 8(2):1139-1149. PubMed ID: 33434417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.